At Aktiia, we believe the key to improving cardiovascular health is to provide patients and physicians a deeper understanding of the blood pressure pattern. Before Aktiia, it was not possible to do this at scale.
We are an early-stage, venture-backed start-up that has raised over $28M from top-tier investors in Europe and the United States. We have developed and brought to market the world’s first continuous blood pressure monitor. Our technology is based on 15 years of research by our founders at the prestigious Swiss Center for Electronics and Microtechnology (CSEM). Aktiia's solution has been validated through extensive clinical trials and received the CE Mark as a Class IIa medical device giving us commercial access to 43 countries worldwide.
Aktiia currently has employees in seven countries and is expanding rapidly.